Introduction
Ibuprofen -the derivative of DL-[2-(4-isobutylphenyl)]-propionic acid from the group of non-steroidal antiinflammatory drugs (NSAIDs), demonstrates in vitro relatively weak blocking of COX-1 and at the same time moderately strong anti-inflammatory activity resulting from COX-2 blocking. These beneficial parameters of in vitro studies suggesting low gastrotoxicity have been confirmed in the studies on the safety of ibuprofen application in paediatric practice [1] [2] [3] [4] [5] .
In comparative studies on ibuprofen and paracetamol, ibuprofen demonstrated stronger and longer-lasting antipyretic activity and stronger analgesic activity [6] [7] [8] . Immediate administration of ibuprofen during fever in children aged 6 months to 12 years with bronchial asthma does not increase the risk of asthma exacerbation [9] . Thus, ibuprofen is a widely applied drug in pediatric health service [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] .
In pediatric health service, ibuprofen is used in the form of suspensions, effervescent granules [20] and in inpatient health service in intravenous form [21] .
In home conditions, application of ibuprofen in the form of a suspension to children up to 3 years of age is not a precise way of dosing a therapeutic substance (choking on suspension, spitting out, vomiting) [22] .
Furthermore, in children who are frequently sick, it increases the risk of occurrence of early dental caries. To decrease the risk of occurrence of early dental caries in children up to 3 years of age, the application of sugar-free drugs e.g. with sorbitol is recommended. Sorbitol belongs to a group of polyhydric sugar alcohols (polyols). A human organism is used to sorbitol uptake because it is a natural product found, among others, in apple juice, prunes, cherries, peaches. In pharmacology sorbitol is administered orally, per rectum (laxative) and intravenously in infusions -dependently on the concentration it has osmotic or nutritious action. According to Polish Pharmacopoeia sixth edition (FP VI) a single oral and daily dose usually applied in the case of sorbitol is 10g, whereas the maximal dose is 20g. Sorbitol is also widely used in pharmaceutical technology in the production of tablets, capsules, syrups, suspensions, dermatological and dental preparations. Due to high level of sweetness (0,5 -0,7 in relation to saccharose) and to the production of heat which results in a cooling effect during tablet sucking, it is an adjuvant substance in the production of sucking tablets [23] [24] [25] [26] [27] .
The aim of the study was to work out a prescription for a teat tablet with sodium ibuprofen placed in a matrice on the base of sorbitol and to compare the profile of therapeutic agent release from the produced form of drug dependently on sorbitol content.
Material and Methods
The studies were performed at the Department of Applied Pharmacy, Medical University in Łódź. 
Formulation of tablets
Three variants of tablets containing dosed amounts of sodium ibuprofen (50 mg),which differed in percentage content of sorbitol (from 37% -batch I to 79% -batch III), were produced by wet granulation method. Polyvinylpyrrolidone increasing viscosity and bioadhesiveness of the tested preparations and magnesium stearate as lubricating agent were used as auxiliary substances.
Quality tests
The produced tablet batches were subjected to physicochemical investigations in compliance with requirements of FP VI [28] . 
Dissolution test
The testing of the sodium ibuprofen rate of release from the produced tablets was performed with the paddle method recommended by FP VI [28] and European Pharmacopoeia [29] . To make the conditions of therapeutic agent release most similar to the conditions present in a child's oral cavity, an additional research method was suggested with the use of NUK-type teat for children [23] . The dissolution test was tested for 6 tablets from each batch.
The amount of the released sodium ibuprofen was determined with spectrophotometric method at the wave length 223 nm vs. standard obtained by manufacturing placebo tablets.
Teat tablet with sodium ibuprofen: the effect of sorbitol on therapeutic agent pharmaceutical availability and on physicochemical parameters of a drug form
Total amount of the therapeutic agent dissolved after time t was calculated according to the formula:
C o -C t = V/v . C t + m i , where: C o -C t -total amount of the substance dissolved after time t, V-fluid volume in which the tablet is immersed, v -the volume of solution taken for analysis, C t -amount of substance determined in sample v, m i -total amount of substance determined in samples collected previously.
Coefficient Q allowed for the comparison of the profile of sodium ibuprofen release from tablets of each batch dependently on the applied research method. According to PP VI definition the coefficient Q is expressed in per cent Mount of therapeutic substance released to the solution at the determined in the monograph precise time of sample collection in relation to the declared content of the therapeutic substance in a tablet. The coefficient Q was calculated from the formula: Q = C/D · 100 where: Q -release coefficient expressed in %, C -amount of therapeutic agent released to the solution in grams, D -declared content of therapeutic agent in a tablet in grams.
The results of the carried out tests were subjected to statistical analysis based on Statistica 5.1 G (StatSoft for Windows and Windows 95/NT).
Results
Basic physicochemical values of the produced tablet batches are demonstrated in Table 1 .
The produced tablets in each batch had a smooth surface, no stains, uniform shape and orange colour originating from earlier moistened PVP.
No chips or mechanical defects were detected on the tested tablet edges, which was confirmed by testing the tablets mechanical resistance to abrasion (the loss of total mass did not exceed 1% in all cases) and mechanical strength ( Table 1) .
The content of the therapeutic agent is in accordance with the designed content and is within the standard of FP VI that is within the range of 95-105% of the declared value ( Table 1) .
The results of tests of the homogeneity of the investigated tablets mass are presented in Table 2 .
The limit of the permissible deviation from mean tablet mass, arithmetical mean of tablet mass and standard deviation and standard error were calculated using Statistical 5.1 software.
Very low values of standard deviation and standard error (Table 2 ) point to high uniformity of mass of the tested tablets.
The results of the testing of disintegration time of the produced tablets are demonstrated in Figure 1 .
The disintegration time of all the tested batches did not exceed 25 min. The shortest disintegration time was obtained for tablets from batch III of the highest content of sorbitol (79%).
The graphic interpretation of the dependence of the release coefficient Q = f (t) obtained in the tests of tablets with paddle method is presented in Figure 2 .
The highest pharmaceutical availability (the rate of release and Q coefficient value) was obtained for tablets from batch III. Slightly slower but uniform release of therapeutic agent was observed from the tablets of batch II and I.
The tests of sodium ibuprofen release by teat method were performed only for batch III tablets. High content bioadhesive components in batch I and II tablets made part of the tablet remain inside the teat.
The obtained results were compared to those obtained in the tests with paddle method (Figure 3) .
Different profiles of release were observed dependently on the applied methodology (pharmacopeal method, method with the use of a teat). The course of the process of release was definitely faster during the tests with paddle method -at the 20 th minute pharmaceutical availability of sodium ibuprofen was over 80%.
Discussion
Problems with the administration of an appropriate dose of therapeutic agent in a suspension to children up to 3 years of age in home conditions and the possibility of the occurrence of early caries after application of sweet and sticky syrups contributed to undertaking studies on the prescription of a teat tablet with sodium ibuprofen.
Sorbitol, saccharic polyalcohol of confirmed cariostatic activity and in addition to this, masking the taste and smell of the therapeutic agent were used in tablets formulations.
The methodology and prescription of model tablets enabled to avoid technological problems during tableting process. Obtaining adequate thickness and bulk density of the tablet mass reflected in uniform and homogenous pouring of the mixture into the matrice, enabled getting tablets of demanded mass (m t [g]) resulting from the prescription and density (appropriate tablet size in relation to its mass) ( Table 2 ). This was visible to the "naked eye" because the effect of flowing in a beaker during release test was not observed in all the tested tablets of all batches [23] [24] [25] [26] [27] .
Insignificant problems appeared during tableting batch III tablets of the highest percentage content of sorbitol. A slight lining of the mixture to punches was observed. The problem which could have resulted from sorbitol high hygroscopicity was solved by increasing the amount of lubricating agent -magnesium stearate -from 0.5% to 1.0%. It is small percentage share in total tablet mass and it does not affect pharmaceutical availability of the therapeutic agent [23] [24] [25] [26] [27] .
Batch III tablets with the highest percentage content of sorbitol are the formulation providing the best pharmaceutical availability in the presence of optimal technological and morphological parameters (the highest hardness, the shortest disintegration time (Figure 1) , adequate tablet mass and density ( Table 1) . Taking into account pharmacotherapeutic aspect, this is also the most appropriate prescription because rapid therapeutic effect is expected in the case of analgesics, antifebrile Teat tablet with sodium ibuprofen: the effect of sorbitol on therapeutic agent pharmaceutical availability and on physicochemical parameters of a drug form and anti-inflammatory agents. Simultaneously, taking into account the fact that mean sorbitol content in the produced tablets is 0.2g, so administering a tablet 3 -4 times a day, a child will get 0.6 -0.8g of sorbitol in divided doses. Thus, there is no risk of the stimulation of laxative action. The use in this experiment a properly prepared teat, forced flow of acceptor fluid by establishing appropriate rate of mixing, made the test (with own research method with the use of NUK-type teat) resemble at most the conditions found in a child's oral cavity. In the method with the use of a teat the therapeutic agent is released more slowly and more evenly into acceptor fluid than during the tests with paddle method where the whole surface of a tablet is made available for the acceptor fluid ( Figure 3) . A teat creates a kind of an internal compartment for these tablets, into which saliva must be sucked first and then, after dissolving, formulation components penetrate into acceptor fluid. In the tests the declared dose of therapeutic agent is released by two methods. In the case of batch III tablets of low content of adjuvant bioadhesive substances the tablet mass was not observed to remain inside the teat in the course of the experiment [23] [24] [25] [26] [27] 30, 31] .
Owing to small selection of pediatric drug forms, the suggested teat tablet using natural sucking reflex is a safe and comfortable alternative to administer a therapeutic agent to children up to 3 years of age.
In conclusion, teat tablets with sodium ibuprofen of the highest sorbitol content (formulation III, 79% of sorbitol) demonstrate the expected physicochemical parameters and high pharmaceutical availability.
